Art. 86 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 61×
1.

For the purposes of this Title, ‘advertising of medicinal products’ shall include any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, supply, sale or consumption of medicinal products; it shall include in particular:

the advertising of medicinal products to the general public,

advertising of medicinal products to persons qualified to prescribe or supply them,

visits by medical sales representatives to persons qualified to prescribe medicinal products,

the supply of samples,

the provision of inducements to prescribe or supply medicinal products by the gift, offer or promise of any benefit or bonus, whether in money or in kind, except when their intrinsic value is minimal,

sponsorship of promotional meetings attended by persons qualified to prescribe or supply medicinal products,

sponsorship of scientific congresses attended by persons qualified to prescribe or supply medicinal products and in particular payment of their travelling and accommodation expenses in connection therewith.

2.

The following are not covered by this Title:

the labelling and the accompanying package leaflets, which are subject to the provisions of Title V,

correspondence, possibly accompanied by material of a non-promotional nature, needed to answer a specific question about a particular medicinal product,

factual, informative announcements and reference material relating, for example, to pack changes, adverse-reaction warnings as part of general drug precautions, trade catalogues and price lists, provided they include no product claims,

information relating to human health or diseases, provided that there is no reference, even indirect, to medicinal products.

The 10 that are cited most themselves, of 61.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Third Chamber) of 1 October 2020. A v Daniel B and Others.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’ of Directive 2001/83 contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    1 Oct 2020 · 62018CJ0649

  • Directive (EU) 2005/29Law

    … věst. L 80, 18.3.1998, s. 27.] Články 86 až 100 směrnice Evropského parlamentu a Rady 2001/83/ES ze dne 6. listopadu 2001 o kodexu Společenství týkajícím se humánních léčivých přípravků [Úř. věst. L 311, 28.11.2001, …

  • Judgment of the Court (Fourth Chamber) of 15 July 2021. DocMorris NV v Apothekerkammer Nordrhein.Decision

    The referring court notes that only advertising of a particular product falls within the scope of the HWG, as opposed to general advertising for an undertaking. However, advertising for the entire range of products of a pharmacy, such as …

    15 Jul 2021 · 62020CJ0190

  • Judgment of the Court (Third Chamber) of 5 May 2011. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    As regards the concept of ‘advertising of medicinal products’, Article 86(1) of Directive 2001/83 defines that concept as ‘any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, …

    5 May 2011 · 62009CJ0316

  • Judgment of the Court (Second Chamber) of 2 April 2009. Criminal proceedings against Frede Damgaard.Decisioninterprets

    On those grounds, the Court (Second Chamber) hereby rules: Article 86 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as amended …

    2 Apr 2009 · 62007CJ0421

  • Judgment of the Court (Grand Chamber) of 22 December 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decisioninterprets

    This request for a preliminary ruling concerns the interpretation of Article 86(1), Article 87(3) and Article 90 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to …

    22 Dec 2022 · 62020CJ0530

  • BGH, Urteil vom 18. November 2021 - I ZR 214/18Decision

    … 1 Nr. 1 HWG stimmt nicht mit dem Begriff der "Werbung für Arzneimittel" im Sinne von Art. 86 Abs. 1 der Richtlinie 2001/83/EG überein (Aufgabe BGH, Urteil vom 13. März 2008 - I ZR 95/05, GRUR 2008, 1014 Rn. 21 - Amlodipin), sondern geht …

    18 Nov 2021 · KORE312192022

  • BGH, EuGH-Vorlage vom 20. Februar 2020 - I ZR 214/18Decision

    (1) Nach der Bestimmung des Art. 86 Abs. 1 der Richtlinie 2001/83/EG gelten als "Werbung für Arzneimittel" alle Maßnahmen zur Information, zur Marktuntersuchung und zur Schaffung von Anreizen mit dem Ziel, die Verschreibung, die Abgabe, …

    20 Feb 2020 · KORE307512020

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision

    In the case of advertising of medicinal products, the Court has already held that, even where it is carried out by an independent third party outside any commercial or industrial activity, such advertising is liable to harm public health, …

    22 Apr 2010 · 62009CJ0062